News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

First Patient Enrolled in W. L. Gore & Associates, Inc. Septal Occluder Clinical Study for Atrial Septal Defect


10/26/2012 8:01:00 AM

FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates (Gore) today reported the first patient enrolled in the GORE® Septal Occluder Clinical Study evaluating the safety and efficacy of the new GORE Septal Occluder in the treatment of percutaneous, trancatheter closure of ostium secundum atrial septal defect (ASD). The patient was successfully treated at Duke University Medical Center in Durham, North Carolina by John Rhodes, MD, Chief of the Congenital Heart Center; and Mandy Green, FNP-C.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES